Dataset | Â | Gene selection method | |||||||
---|---|---|---|---|---|---|---|---|---|
MaPSOGS | Geometric PSO | PSO | RMA | RPSW | EPSO | Hybrid BPSO-BBHA | PSOC4.5 | ||
AMLGSE2191 | Acc (%) | 97.08 (1) | 86.65 (7) | 80.90 (8) | 95.11 (2) | 91.18 (5) | 90.01 (6) | 91.63 (4) | 94.05 (3) |
 | Std | 5.08 | 4.45 | 6.16 | 3.96 | 4.39 | 3.88 | 4.24 | 2.77 |
Colon | Acc (%) | 96.52 (1) | 87.05 (7) | 84.09 (8) | 94.89 (2) | 91.55 (4) | 89.14 (6) | 90.95 (5) | 92.64 (3) |
 | Std | 2.29 | 3.65 | 4.02 | 2.07 | 4.78 | 3.95 | 2.47 | 3.95 |
DLBCL | Acc (%) | 94.57 (1) | 85.62 (7) | 81.33 (8) | 92.63 (2) | 91.07 (3) | 90.22 (5) | 89.96 (6) | 90.91 (4) |
 | Std | 1.54 | 5.72 | 6.16 | 2.85 | 4.66 | 3.39 | 7.05 | 4.48 |
Leukaemia | Acc (%) | 95.42 (1) | 83.39 (7) | 82.12 (8) | 92.89 (2) | 89.69 (4) | 88.43 (6) | 88.53 (5) | 91.57 (3) |
 | Std | 0.86 | 4.17 | 4.55 | 1.01 | 2.33 | 3.97 | 3.91 | 1.93 |
Prostate | Acc (%) | 96.71 (1) | 81.93 (8) | 83.05 (7) | 95.09 (2) | 90.28 (4) | 86.14 (6) | 87.19 (5) | 91.18 (3) |
 | Std | 3.75 | 4.99 | 7.87 | 2.05 | 5.66 | 2.84 | 5.41 | 2.97 |
MLL | Acc (%) | 93.44 (1) | 80.98 (7) | 79.24 (8) | 90.93 (2) | 85.87 (5) | 89.88 (4) | 85.28 (6) | 90.22 (3) |
 | Std | 2.12 | 5.83 | 5.75 | 4.16 | 2.49 | 4.18 | 6.17 | 3.63 |
SRBCT | Acc (%) | 95.85 (1) | 81.66 (8) | 80.88 (7) | 92.16 (2) | 90.02 (5) | 90.75 (4) | 89.97 (6) | 91.76 (3) |
 | Std | 4.09 | 7.02 | 6.58 | 3.90 | 5.54 | 5.40 | 4.11 | 3.75 |
Average | Acc (%) | 95.65 (1) | 83.89 (7.28) | 81.66 (7.71) | 93.38 (2) | 89.95 (4.28) | 89.22 (5.28) | 89.07 (5.28) | 91.76 (3.14) |
 | Std | 2.82 | 5.12 | 5.87 | 2.86 | 4.26 | 3.94 | 4.76 | 3.35 |